Cagrilintide 10mg: The Breakthrough Peptide for Ultimate Appetite Control
Do you feel like you’re constantly fighting a losing battle against your appetite? The secret to successful weight loss isn’t just about willpower—it’s about hormones. Cagrilintide is a revolutionary peptide that harnesses the power of amylin, one of your body’s most important natural satiety hormones, to help you finally gain the upper hand over hunger and achieve your weight loss goals.
Cagrilintide is a long-acting amylin analogue, engineered to provide a sustained and powerful feeling of fullness that lasts. In clinical trials, it has demonstrated significant, dose-dependent weight loss, both as a standalone therapy and as part of the powerful CagriSema combination. For individuals in the US, UK, and Australia who need a powerful tool to control their calorie intake, Cagrilintide is a game-changer.
- Powerful and Sustained Satiety: Mimics the hormone amylin to send strong “I’m full” signals to your brain, helping you naturally eat less without feeling deprived.
- Significant Weight Loss: As a standalone therapy, Cagrilintide has been shown to produce superior weight loss compared to other medications, with users losing up to 10.8% of their body weight in 26 weeks.
- Slows Digestion to Keep You Full Longer: Delays gastric emptying, the process by which food leaves your stomach, prolonging the feeling of satisfaction after meals.
- The Perfect Partner for GLP-1s: Works via a complementary pathway to GLP-1 agonists like Semaglutide, creating a synergistic effect for unprecedented weight loss when used in combination (as CagriSema).
Status: In Stock

How Does Cagrilintide Work? The Science of Amylin
Every time you eat, your pancreas releases two key hormones: insulin and amylin. While insulin manages your blood sugar, amylin’s job is to tell your brain that you’re full. It’s a crucial part of your body’s natural appetite control system.
Mimicking and Enhancing Your Body’s Natural Signals
Cagrilintide is a synthetic molecule designed to mimic and amplify the effects of amylin. It works through a dual mechanism:
- In the Brain: It acts on amylin and calcitonin receptors in key areas of the brain that control food intake, generating a powerful and lasting feeling of satiety.
- In the Gut: It slows down the rate at which your stomach empties, meaning you feel physically fuller for much longer after a meal.
This combination of central (brain) and peripheral (gut) action makes Cagrilintide an incredibly effective tool for reducing overall calorie consumption and driving weight loss.
Who Can Benefit from Cagrilintide?
Cagrilintide is an ideal solution for individuals whose primary barrier to weight loss is an overactive appetite and difficulty controlling portion sizes.
- Individuals Who Struggle with Constant Hunger: If you feel hungry soon after eating or struggle with large portion sizes, Cagrilintide can help reset your body’s fullness cues.
- People Seeking a Powerful Standalone Therapy: Clinical trials have shown Cagrilintide is highly effective on its own for weight management.
- Advanced Users Looking to Maximize Results: For those already using a GLP-1 agonist, adding an amylin analogue like Cagrilintide (in a combination like CagriSema) can take weight loss results to the next level by targeting a complementary pathway.
Frequently Asked Questions About Cagrilintide
Is Cagrilintide a GLP-1 agonist?
No. Cagrilintide is an amylin analogue. It works on a different set of receptors than GLP-1 agonists like Semaglutide or Tirzepatide. This is why they work so well together—they tackle appetite from two different angles.
How much weight can I lose with Cagrilintide alone?
In a 26-week Phase 2 trial, participants taking the highest dose of Cagrilintide lost an average of 10.8% of their body weight, which was superior to the 9.0% lost by those taking liraglutide 3.0mg (another weight loss medication).
What are the side effects of Cagrilintide?
Similar to other hormonal weight loss medications, the most common side effects are gastrointestinal, such as nausea and vomiting. These are typically mild to moderate and tend to decrease over time.
Is Cagrilintide approved for use?
Cagrilintide is an investigational medication and is not yet approved by the FDA or other regulatory bodies as a standalone therapy. It is currently in late-stage trials, primarily in combination with Semaglutide as CagriSema.
Reviews
There are no reviews yet.